Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report

BACKGROUND: Primary myelofibrosis is a myeloproliferative disorder characterized by bone marrow fibrosis, abnormal cytokine expression, splenomegaly and anemia. The activation of JAK2 and the increased levels of circulating proinflammatory cytokines seem to play an important role in the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomba, Claudia, Rubino, Raffaella, Siracusa, Lucia, Lalicata, Francesco, Trizzino, Marcello, Titone, Lucina, Tolomeo, Manlio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515333/
https://www.ncbi.nlm.nih.gov/pubmed/23039051
http://dx.doi.org/10.1186/1756-0500-5-552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515333/
https://www.ncbi.nlm.nih.gov/pubmed/23039051
http://dx.doi.org/10.1186/1756-0500-5-552

Ejemplares similares